Plasma levels of N-terminal proatrial natriuretic peptide in children are dependent on renal function and age

REFERENCES

• Edwards BS, Zimmerman RS, Schwab TR, Heublein DM, Burnett JC, Jr. Atrial stretch, not pressure, is the principal determinant control-ling the acute release of atrial natriuretic factor. Circ Res 1988; 62: 191–5.
   PubMed Web of Science ®Google Scholar
• Nicholls MG. The natriuretic peptides in heart failure. J Intern Med 1994; 235: 515–26.
   PubMed Web of Science ®Google Scholar
• Ruskoaho H. Atrial natriuretic peptide: synthesis, release, and metabolism. Pharmacol Rev 1992; 44: 479— 602.
   PubMed Web of Science ®Google Scholar
• Dickstein K, Larsen Al, Bonarjee V, Thoresen M, Aarsland T, Hall C. Plasma proatrial natriuretic factor is predictive of clinical status in patients with congestive heart failure. Am J Cardiol 1995; 76: 679–83.
   PubMed Web of Science ®Google Scholar
• Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, et al. Circulat-ing N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunc-tion. Lancet 1993; 341: 1105–9.
   PubMed Web of Science ®Google Scholar
• Yandle TG. Biochemistry of natriuretic peptides. J Intern Med 1994; 235: 561–76.
   PubMed Web of Science ®Google Scholar
• Levin ER, Gardner DG, Samson WK. Natriuretic peptides. N Engl J Med 1998; 339: 321–8.
   PubMed Web of Science ®Google Scholar
• Sundsfjord JA, Thibault G, Larochelle P, Cantin M. Identification and plasma concentrations of the N-terminal fragment of proatrial natriuretic factor in man. J Clin Endocrinol Metab 1988; 66: 605 — 10.
   PubMed Web of Science ®Google Scholar
• Katsube N, Schwartz D, Needleman P. Atriopep-tin turnover: quantitative relationship between in vivo changes in plasma levels and atrial content. J Pharmacol Exp Ther 1986; 239: 474–9.
   Google Scholar
• Bonarjee VV, Omland T, Nilsen DW, Caidahl K, Sundsfjord JA, Dickstein K. Plasma proatrial natriuretic factor (1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function. Br Heart J 1995; 73: 511–6.
   PubMedGoogle Scholar
• Holmstrom H, Thaulow E, Stokke 0, Lindberg H, Hall C. Serum N-terminal proatrial natriuretic factor in children with congenital heart disease. Eur Heart J 1996; 17: 1737–46.
   Google Scholar
• Holmstrom H, Hall C, Stokke 0, Lindberg H, Thaulow E. Hemodynamic background of the elevation of N-terminal natriuretic peptide pro-hormone in children with congenital heart disease. Card Young 1999; 9: 141–9.
   Google Scholar
• Sjoberg S, Hellsten S, Almen T, Golman K, Gronberg T. Estimating kidney function during urography. Comparison of contrast medium clearance and simultaneous 51Cr-EDTA clear-ance. Acta Radiol 1987; 28: 587–92.
   Google Scholar
• Stake G, Monn E, Rootwelt K, Monclair T. A single plasma sample method for estimation of the glomerular filtration rate in infants and children using iohexol. II: Establishment of the optimal plasma sampling time and a comparison with the 99Tcm—DTPA method. Scand J Clin Lab Invest 1991; 51: 343–8.
   Google Scholar
• Boijsen M, Granerus G, Jacobsson L, Bjorneld L, Aurell M, Tylen U. Glomerular filtration rate estimated after multiple injections of contrast medium during angiography. Acta Radiol 1988; 29: 669–74.
   PubMed Web of Science ®Google Scholar
• Haycock GB, Dalton N Laboratory investigation. In: Holliday MA, Barratt TM, Avner ED, editors. Pediatric nephrology. 3rd ed. Baltimore: Williams and Wilkins, 1994: 397 — 420
   Google Scholar
• Dahle M, Simonsen S, Hall C, Kjekshus J. Power of plasma N-terminal proatrial natriuretic factor to determine haemodynamics in patients with cardiac disease: relation to serum creatinine. Scand J Clin Lab Invest 1998; 58: 395–404.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Nakao K, Hayashi K, Morii N, Sugawara A, Sakamoto M, et al. Ontogeny of atrial natriuretic polypeptide in the human heart. Acta Endocrinol 1987; 115: 211–7.
   PubMedGoogle Scholar
• Chien R. Signaling mechanisms for the activation of an embryonic gene program during the hypertrophy of cardiac ventricular muscle. Basic Res Cardiol 1992; 87 Suppl; 2: 49–58.
   Google Scholar
• Jougasaki M, Yasue H, Okumura K, Mukoyama M, Saito Y, Nakao K, et al. Atrial natriuretic peptide in the ventricles of patients with dilated cardiomyopathy and human foetuses. Histochem J 1989; 21: 715–20.
   PubMedGoogle Scholar
• Ekblad H, Kero P, Vuolteenaho 0, Arjamaa 0, Korvenranta H, Shaffer SG. Atrial natriuretic peptide in the preterm infant. Lack of correlation with natriuresis and diuresis. Acta Paediatr 1992; 81: 978–82.
   Google Scholar
• Stephenson TJ, Broughton Pipkin F, Hetmanski D, Yoxall B. Atrial natriuretic peptide in the preterm newborn. Biol Neonate 1994; 66: 22–32.
   PubMedGoogle Scholar
• Ikemoto Y, Nogi S, Teraguchi M, Kojima T, Hirata Y, Kobayashi Y. Early changes in plasma brain and atrial natriuretic peptides in premature infants: correlation with pulmonary arterial pres-sure. Early Hum Dev 1996; 46: 55–62.
   PubMed Web of Science ®Google Scholar
• Weil J, Bidlingmaier F, Dohlemann C, Kuhnle U, Strom T, Lang RE. Comparison of plasma atrial natriuretic peptide levels in healthy children from birth to adolescence and in children with cardiac diseases. Pediatr Res 1986; 20: 1328–31.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Shiomi M, Hone K, Ohie T, Nakao K, Imura H, et al. Plasma atrial natriuretic polypeptide concentration in healthy children from birth to adolescence. Acta Paediatr Scand 1988; 77: 380–4.
   PubMed Web of Science ®Google Scholar
• Heilbron DC, Holliday MA, al-Dahwi A, Kogan BA. Expressing glomerular filtration rate in children. Pediatr Nephrol 1991; 5: 5–11.
   PubMed Web of Science ®Google Scholar
• Edwards BS, Ackermann DM, Lee ME, Reeder GS, Wold LE, Burnett JC, Jr. Identification of atrial natriuretic factor within ventricular tissue in hamsters and humans with congestive heart fail-ure. J Clin Invest 1988; 81: 82–6.
   Google Scholar
• Yasue H, Obata K, Okumura K, Kurose M, Ogawa H, Matsuyama K, et al. Increased secre-tion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 1989; 83: 46–51.
   PubMed Web of Science ®Google Scholar
• Neri B, De Scalzi M, De Leonardis V, Gemelli MT, Ghezzi P, Pacini P. Preliminary study on behaviour of atrial natriuretic factor in anthracy-dine-related cardiac toxicity. Int J Clin Pharmacol Res 1991; 11: 75–81.
   PubMedGoogle Scholar
• Bauch M, Ester A, Kimura B, Victorica BE, Kedar A, Phillips MI. Atrial natriuretic peptide as a marker for doxorubicin-induced cardiotoxic effects. Cancer 1992; 69: 1492–7.
   PubMed Web of Science ®Google Scholar
• Meberg A, Otterstad J, Hals J, Sol.land S. Early clinical screening of neonates for congenital heart defects: the cases we miss. Card Young 1999; 9: 169— 74.
   PubMed Web of Science ®Google Scholar